Reduced rat plasma lysophosphatidylglycerol or lysophosphatidic acid level as a biomarker of aristolochic acid-induced renal and adipose dysfunctions
-
Add time:07/26/2019 Source:sciencedirect.com
AimsFood products and diet pills containing aristolochic acid (AA) are responsible for a rapid progression of nephropathy associated with reduced body weight in human beings. In this study, we investigated the relationship of dietary NaCl and lysophospholipid (LPL) plasma levels to body weight gain in AA-treated rats.
We also recommend Trading Suppliers and Manufacturers of ARISTOLOCHIC ACID SODIUM SALT (cas 10190-99-5). Pls Click Website Link as below: cas 10190-99-5 suppliers
Prev:Aristolochic acid I is a substrate of BCRP but not P-glycoprotein or MRP2
Next:Protective effects of cyclic helix B peptide on aristolochic acid induced acute kidney injury) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Developmental nephrotoxicity of aristolochic acid in a zebrafish model07/31/2019
- Induction of cytochromes P450 1A1 and 1A2 suppresses formation of DNA adducts by carcinogenic aristolochic acid I in rats in vivo07/30/2019
- Is aristolochic acid nephropathy a widespread problem in developing countries?07/29/2019
- Aristolochic acid I interferes with the expression of BLCAP tumor suppressor gene in human cells07/28/2019
- Protective effects of cyclic helix B peptide on aristolochic acid induced acute kidney injury07/27/2019
- Aristolochic acid I is a substrate of BCRP but not P-glycoprotein or MRP207/25/2019
- Oral exposure to aristolochic acid I induces gastric histological lesions with non-specific renal injury in rat07/24/2019
- Comparison of Aristolochic acid I derived DNA adduct levels in human renal toxicity models07/23/2019
-
Health and Chemical more >